Efficacy of Intramammary Tilmicosin at Drying-off, and Other Risk Factors, for Prevention of New Intramammary Infections during the Dry Period
DOI:
https://doi.org/10.21423/aabppro20025083Keywords:
intramammary infusion, tilmicosin phosphate, placebo, intramammary infectionsAbstract
This study compared the efficacy of an intramammary infusion containing tilmicosin phosphate to an infusion of a negative-control intramammary placebo for preventing new intramammary infections (IMI) during the dry period.